III.J.18. Medical Countermeasures for Yersinia pestis. Develop medical countermeasures against the biological threat of Yersinia pestis, the causative agent of plague. By FY95, complete an assessment of the efficacy of the Cutter vaccine against an aerosol challenge of Yersinia pestis. By FY98, transition to development a vaccine that will protect 80 percent of immunized personnel against an aerosol challenge of Yersinia pestis and will induce minimum reactogenicity in soldiers when immunized.
Supports: Army Modernization Plan, Medical Annex OProject, Sustain, and Protect the Force by Development of NBC Agent Preventive Measures. Provides for the exploration, demonstration, and validation of biological defense vaccines as outlined by the DEPSECDEF (26 Aug 91) and the Joint Requirements Oversight Council (31 Aug 92)
|STO Manager:||TSO:||TRADOC POC:|
|Dr. Anna Johnson-Winegar||MAJ Mark Seymour||CPT Ensor|